Pharmacokinetics, Exposure-Response Relationships, and Immunogenicity in Crohn's Disease Patients With Ustekinumab Secondary Loss of Response Following Ustekinumab IV Re-Induction: Week 16 Results From the POWER Study

被引:0
|
作者
Feagan, Brian G. [1 ]
Lee, Scott D. [2 ]
van der Woude, C. Janneke [3 ]
Marin-Jimenez, Ignacio [4 ]
Wolf, Douglas C. [5 ]
Schnoy, Elisabeth [6 ]
Salzberg, Bruce [7 ]
Busse, Christopher [8 ]
Nazar, Maciej [9 ]
Langholff, Wayne [10 ]
Gasink, Christopher [8 ]
Baker, Thomas [10 ]
Godwin, Bridget [8 ]
Adedokun, Omoniyi [10 ]
Schreiber, Stefan [11 ]
机构
[1] Western Univ, London, ON, Canada
[2] Univ Washington, Seattle, WA USA
[3] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[4] Hosp Univ Gregorio Maranon, IiSGM, Rotterdam, Zuid Holland, Netherlands
[5] Atlanta Gastroenterol Associates, Atlanta, GA USA
[6] Univ Hosp Augsburg, Augsburg, Germany
[7] IBD Ctr Atlanta, Atlanta Gastroenterol, Atlanta, GA USA
[8] Janssen Sci Affairs LLC, Horsham, PA USA
[9] Janssen Cilag Polska Sp Zoo, Warsaw, Poland
[10] Janssen Res & Dev LLC, Spring House, PA USA
[11] Univ Hosp Schleswig Holstein, Kiel, Germany
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S842
引用
收藏
页码:S622 / S622
页数:1
相关论文
共 50 条
  • [21] Exposure-Response to SC Ustekinumab In Moderate-Severe Crohn's Disease: Results From the IM-UNITI Maintenance Study
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Gasink, Christopher
    Jacobstein, Douglas
    Szapary, Philippe
    Johanns, Jewel
    Gao, Long Long
    Davis, Hugh M.
    Hanauer, Stephen
    Feagan, Brian G.
    Ghosh, Subrata
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S365 - S365
  • [22] IMMUNOGENICITY OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE IM-UNITI STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Nussbaum, Jeannette
    Oortwijn, Alessandra
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Adedokun, Omoniyi J.
    de Villiers, Willem J.
    Ghosh, Subrata
    GASTROENTEROLOGY, 2019, 156 (06) : S1097 - S1097
  • [23] Single or continuous multiple intravenous re-induction in Crohn's disease patients who lost response to ustekinumab: Evidence from real-world data
    Tang, Jian
    Li, Qing
    Huang, Zhaopeng
    Shi, Lishuo
    Guo, Qin
    Li, Miao
    Gao, Xiang
    Chao, Kang
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (05) : 749 - 755
  • [24] Pharmacokinetics and exposure-response relationship of ustekinumab, a human monoclonal antibody to interleukin 12/23, in patients with moderateto-severe Crohn's disease
    Fasanmade, Adedigbo A.
    Adedokun, Omoniyi J.
    Johanns, Jewel R.
    Zhou, Honghui
    Davis, Hugh M.
    Blank, Marion
    GASTROENTEROLOGY, 2008, 134 (04) : A490 - A490
  • [25] Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's disease
    Hu, Chuanpu
    Adedokun, Omoniyi J.
    Chen, Yang
    Szapary, Philippe O.
    Gasink, Christopher
    Sharma, Amarnath
    Zhou, Honghui
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (05) : 425 - 436
  • [26] Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn’s disease
    Chuanpu Hu
    Omoniyi J. Adedokun
    Yang Chen
    Philippe O. Szapary
    Christopher Gasink
    Amarnath Sharma
    Honghui Zhou
    Journal of Pharmacokinetics and Pharmacodynamics, 2017, 44 : 425 - 436
  • [27] Ustekinumab IV Induction Results in Crohn's Disease Symptom Improvement Within the First Week in Anti-TNF Refractory Patients
    Sandborn, William J.
    Yeager, Benjamin
    Gasink, Christopher
    Hoops, Timothy
    Gao, Long Long
    Wang, Yanli
    Jacobstein, Douglas
    Lee, Scott D.
    Hanauer, Stephen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S403 - S403
  • [28] Ustekinumab IV Induction Results in Crohn's Disease Symptom Improvement Within the First Week in Anti-TNF Refractory Patients
    William, Sandborn
    Benjamin, Yeager
    Christopher, Gasink
    Timothy, Hoops
    Long-Long, Gao
    Wang Yanli
    Douglas, Jacobstein
    Scott, Lee
    Stephen, Hanauer
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S4 - S4
  • [29] Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn's disease: Week 16 interim analysis of the STARDUST trial substudy
    Kucharzik, T.
    Wilkens, R.
    Maconi, G.
    D'Agostino, M. A.
    Le Bars, M.
    Nazar, M.
    Sloan, S.
    Lahaye, M.
    Ni, L.
    Ercole, E.
    Alloca, M.
    Machkova, N.
    Maaser, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S046 - S048
  • [30] INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL HEALING AFTER USTEKINUMAB INDUCTION IN CROHN'S DISEASE: WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL SUBSTUDY
    Kucharzik, Torsten
    Wilkens, Rune
    Maconi, Giovanni
    D'Agostino, Maria-Antonietta
    Le Bars, Manuela
    Nazar, Maciej
    Sloan, Sheldon
    Lahaye, Marjolein
    Ni, Lioudmila
    Ercole, Elena
    Allocca, Mariangela
    Machkova, Nadezda
    Maaser, Christian
    GASTROENTEROLOGY, 2020, 158 (06) : S61 - S61